Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutathione Status in Platelets From Patients With Type 2 Diabetes Treated With N-acetylcysteine
2008-001620-31Phase 4Completed
- Sponsor
- NHS Highland
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of acetylcysteine in Not applicable (platelet aggregation is not a disease) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by NHS Highland. Primary endpoint: Change in platelet activation after 1 week of NAC therapy. Started Aug 2009; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Not applicable (platelet aggregation is not a disease)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001620-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001620-31.